Lincocin

Lincomycin, the active ingredient in Lincocin, is a lincosamide presented as an oral formulation for oral use. It treats a range of bacterial infections, particularly those caused by susceptible gram‑positive and anaerobic organisms, and is prescribed for patients requiring targeted antibiotic therapy.

GNH USA supplies Lincocin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lincocin is a lincosamide antibiotic used to manage infections caused by susceptible bacteria. It is employed in several clinical settings where gram‑positive or anaerobic pathogens are implicated.

- Skin and soft‑tissue infections: reduces bacterial load and promotes healing. - Bone and joint infections: eradicates pathogens in osteomyelitis and septic arthritis. - Intra‑abdominal infections: treats mixed aerobic‑anaerobic infections following surgery or perforation. - Respiratory tract infections: effective against certain community‑acquired pneumonia caused by susceptible strains. - Septicemia: used when bloodstream infection is caused by lincomycin‑sensitive organisms.

Adverse reactions may occur with lincomycin therapy and are categorized by frequency and severity.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: may be watery and self‑limiting. - Vomiting: occasional episodes after dosing. - Abdominal pain: cramp‑like discomfort. - Rash: transient skin erythema. - Eosinophilia: mild increase in eosinophil count.

Serious or Rare Side Effects: - Pseudomembranous colitis: severe colonic inflammation. - Anaphylaxis: acute, potentially life‑threatening allergic reaction. - Hepatic dysfunction: elevated liver enzymes or jaundice. - Neutropenia: significant reduction in neutrophil count. - Stevens‑Johnson syndrome: severe mucocutaneous reaction. - Renal impairment: acute kidney injury in susceptible patients.

Lincomycin should be used with careful clinical assessment and monitoring.

- Assess renal function: adjust therapy in patients with renal insufficiency. - Monitor liver enzymes: watch for hepatic toxicity during prolonged use. - History of colitis: avoid or use with caution in patients with prior Clostridioides difficile infection. - Known hypersensitivity: discontinue if allergic reactions develop. - Use in pregnancy: evaluate risk‑benefit ratio as safety data are limited. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Lincomycin may interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Neuromuscular blocking agents: may potentiate muscle weakness. - Methotrexate: increased risk of hematologic and hepatic toxicity.

Moderate Interactions (Monitor Closely): - Oral contraceptives: possible reduction in contraceptive effectiveness. - Warfarin: may enhance anticoagulant effect, requiring INR monitoring. - Probenecid: may decrease renal clearance of lincomycin. - Erythromycin: competitive inhibition at the bacterial ribosome, potentially altering activity.